GT Biopharma GTBP
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q2 | 12.24 | 4 | 6 | |||
| 2026Q1 | 10.2 | 8 | -42.39 | -3 | -31.3 | 10 |
| 2025Q4 | 19.63 | 6 | -129.92 | -6 | -91.86 | 8 |
| 2025Q3 | 14.66 | 3 | 8 | 145.02 | 4 | |
| 2025Q2 | 89.5 | -26 | -30 | -616.83 | 7 | |
| 2025Q1 | 53.75 | -1 | -1 | -22.53 | 3 | |
| 2024Q4 | 76.25 | -2 | -4 | -68.69 | 4 | |
| 2024Q3 | 57.73 | 2 | -89.7 | -3 | -42.57 | 7 |
| 2024Q2 | 70.75 | 6 | -68.58 | -4 | -38.69 | 9 |
| 2024Q1 | 110.75 | 5 | -35.44 | -2 | -18.87 | 10 |
| 2023Q4 | 191.25 | 7 | -33.89 | -3 | -19.58 | 14 |
| 2023Q3 | 180.83 | 10 | -22.2 | -2 | -14.09 | 16 |
| 2023Q2 | 234 | 12 | -16.05 | -2 | -10.42 | 18 |
| 2023Q1 | 412.5 | 13 | -1.83 | 0 | -1.23 | 20 |
| 2022Q4 | 664.28 | 12 | -40.34 | -6 | -29.54 | 17 |
| 2022Q3 | 1320 | 16 | -43.84 | -7 | -30.42 | 21 |
| 2022Q2 | 2242.5 | 15 | -17.93 | -3 | -11.54 | 24 |
| 2022Q1 | 2160 | 18 | -27.41 | -5 | -18.25 | 27 |
| 2021Q4 | 2287.5 | 22 | -66.8 | -18 | -53.03 | 32 |
| 2021Q3 | 5055 | 32 | -15.92 | -5 | -14.47 | 36 |